Literature DB >> 14750933

Health-related quality of life assessment in adult haemophilia patients: a systematic review and evaluation of instruments.

A Szende1, W Schramm, E Flood, P Larson, E Gorina, A M Rentz, L Snyder.   

Abstract

The objective of this study was to review and evaluate the performance of health-related quality of life (HRQL) and other health status measures used in studies of adult haemophilia and provide recommendations for future research. A systematic literature review was performed to identify HRQL and health status measures used in haemophilia. Literature was identified using medical databases, Internet and manual searches. The search was restricted to articles published in English since 1986. Ninety-six abstracts were located; 19 relevant articles were selected for detailed review. Three main types of HRQL measures were identified: generic psychometric-based HRQL (SF-36 and SF-12), utility-based HRQL [EQ-5D and Health Utilities Index (HUI)], and musculoskeletal-specific HRQL (Arthritis Impact Measurement Scale 2, AIMS 2) instruments. No patient-rated haemophilia-specific HRQL instrument was found. The SF-36, the EQ-5D, and the HUI were able to discriminate haemophilia patient subgroups with respect to disease severity and HIV comorbidity status. Sixteen additional scales were identified that were used to measure the different aspects of physical, psychological, and social functioning of patients. There were no clinical studies of haemophilia carried out that employed HRQL instruments, thus responsiveness of these instruments could not be evaluated. The variety of instruments used in haemophilia studies highlights the need for a tool that can capture the full impact of haemophilia and its treatment on patients' HRQL. Developing such a tool poses the unique challenge of accounting for common comorbidities, such as HIV and chronic hepatitis that may have a greater HRQL impact than the underlying disease.

Entities:  

Mesh:

Year:  2003        PMID: 14750933     DOI: 10.1046/j.1351-8216.2003.00823.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  6 in total

Review 1.  Evaluation of the methodological quality of systematic reviews of health status measurement instruments.

Authors:  Lidwine B Mokkink; Caroline B Terwee; Paul W Stratford; Jordi Alonso; Donald L Patrick; Ingrid Riphagen; Dirk L Knol; Lex M Bouter; Henrica C W de Vet
Journal:  Qual Life Res       Date:  2009-02-24       Impact factor: 4.147

Review 2.  Estimates of utility weights in hemophilia: implications for cost-utility analysis of clotting factor prophylaxis.

Authors:  Scott D Grosse; Shraddha S Chaugule; Joel W Hay
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2015-01-14       Impact factor: 2.217

3.  The social burden and quality of life of patients with haemophilia in Italy.

Authors:  Yllka Kodra; Marianna Cavazza; Arrigo Schieppati; Marta De Santis; Patrizio Armeni; Romano Arcieri; Gabriele Calizzani; Giovanni Fattore; Lamberto Manzoli; Lorenzo Mantovani; Domenica Taruscio
Journal:  Blood Transfus       Date:  2014-04       Impact factor: 3.443

4.  Patient preference and ease of use for different coagulation factor VIII reconstitution device scenarios: a cross-sectional survey in five European countries.

Authors:  Ernesto Cimino; Silvia Linari; Mara Malerba; Susan Halimeh; Francesca Biondo; Martina Westfeld
Journal:  Patient Prefer Adherence       Date:  2014-12-12       Impact factor: 2.711

5.  Shared topics on the experience of people with haemophilia living in the UK and the USA and the influence of individual and contextual variables: Results from the HERO qualitative study.

Authors:  Laura Palareti; Silvia Potì; Frederica Cassis; Francesca Emiliani; Davide Matino; Alfonso Iorio
Journal:  Int J Qual Stud Health Well-being       Date:  2015-11-16

Review 6.  What is the evidence for the performance of generic preference-based measures? A systematic overview of reviews.

Authors:  Aureliano Paolo Finch; John Edward Brazier; Clara Mukuria
Journal:  Eur J Health Econ       Date:  2017-05-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.